The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / A New Role for Lateral Flow in Cancer Diagnosis
Oncology Point of care testing Molecular Pathology

A New Role for Lateral Flow in Cancer Diagnosis

A quantitative colorimetric assay distinguished patients with PDAC from healthy controls

11/19/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

To develop and evaluate a quantitative lateral flow immunoassay for measuring plasma soluble AXL (sAXL) as a potential aid to pancreatic ductal adenocarcinoma (PDAC) diagnosis.

Approach:
  • Assay development: Researchers optimized a colorimetric strip using capture and detection antibodies and anti-biotin gold nanoparticles. They first assessed the immunoreagents in a sandwich ELISA.
  • Evaluation: The lateral flow assay was tested on plasma from 20 patients with PDAC and 20 healthy controls and compared with ELISA measurements.
Key Findings:
  • The sandwich ELISA showed a linear sAXL response and a reported detection limit of 0.16 ng/mL.
  • The lateral flow assay detected higher sAXL concentrations in the PDAC group and statistically differentiated patients from healthy controls.
Interpretation:

The study provides an early evaluation of a quantitative lateral flow format for plasma sAXL measurement; it does not establish the assay for routine diagnosis or screening.

Limitations:
  • The clinical cohort was small and included only patients with PDAC and healthy controls.
  • The assay was not evaluated against chronic pancreatitis, benign pancreatic disease, other cancers, or inflammatory conditions.
  • Sensitivity, specificity, clinical cutoffs, reference intervals, and performance across disease stages remain to be established in larger, independent, multicenter studies.
Conclusion:

The findings do not support replacing imaging, histopathology, cytology, or laboratory ELISA with this assay.

Sources:
  • Article context provided in the prompt

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.